Dan Grande, MD
Dr. Grande is currently Director of Orthopaedic Research and recently appointed Chief of Operations and Strategic Planning at the Feinstein Institute for Medical research. He has worked extensively in the area of regenerative medicine and tissue engineering. His early work helped develop cell based therapy for cartilage repair, currently known as autologous chondrocyte transplantation. He has continued to work on cartilage regeneration combining principles of gene therapy and tissue engineering and more recently in tendon repair which is now a major area of his labs focus. Dr. Grande’s work with ORS includes moderating sessions at the annual meeting, reviewing abstracts, and he has been actively involved in the “meet the mentor’s” luncheon for the past four years since its inception at the annual meeting. He is the author of over 60 peer review publications. Dr. Grande is significantly involved in mentoring and teaching of orthopaedic residents for his department. He has been a reviewer for the following journals: Journal of Orthopaedic Research, Clinical Orthopaedics, Osteoarthritis and Cartilage, American Journal of Sports Medicine, and Applied Biomaterials to name but a few. He has been awarded eight patents and helped found two companies in the orthopaedic surgery field of use. He is also a member of several companies’ scientific advisory boards. Dr. Grande is in year four of a five year rotation with OREF to assist in grant reviews. He regularly serves on NIH study sections for RO1, R21, and SBIR/STTR grants specific to musculoskeletal applications.